These observations are consistent with a study reporting higher levels of IRF1 protein in adjacent normal breast epithelium when compared with high-grade DCIS or lymph node-positive invasive ductal carcinoma of the breast [58]. The gene discussed is IRF1; the disease is ductal breast carcinoma in situ.